CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
Health Briefs
Related Stories
Health Briefs
Oct 07, 2025
FDA grants Breakthrough Therapy Designation to Angelman Syndrome treatment
Health Briefs
Oct 01, 2025
Dr. Mustafa Sahin gives Cain Labs' Inaugural John Swann Lecture in Epilepsy Series September 29, ...
81781
Health Briefs
Article